Cargando…
Peanut Allergy: An Overview
Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their t...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868887/ https://www.ncbi.nlm.nih.gov/pubmed/20525136 http://dx.doi.org/10.1186/1710-1492-4-4-139 |
_version_ | 1782181085559390208 |
---|---|
author | Al-Ahmed, Nasser Alsowaidi, Shirina Vadas, Peter |
author_facet | Al-Ahmed, Nasser Alsowaidi, Shirina Vadas, Peter |
author_sort | Al-Ahmed, Nasser |
collection | PubMed |
description | Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy range from mild to severe, and risk factors predisposing to severe reactions are discussed. However, even in the absence of risk factors, peanut allergic individuals may still experience life-threatening anaphylactic reactions. Approaches to investigation and treatment, patterns of cross-reactivity and possible causes of rising prevalence are discussed. |
format | Text |
id | pubmed-2868887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28688872010-05-13 Peanut Allergy: An Overview Al-Ahmed, Nasser Alsowaidi, Shirina Vadas, Peter Allergy Asthma Clin Immunol Review Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy range from mild to severe, and risk factors predisposing to severe reactions are discussed. However, even in the absence of risk factors, peanut allergic individuals may still experience life-threatening anaphylactic reactions. Approaches to investigation and treatment, patterns of cross-reactivity and possible causes of rising prevalence are discussed. BioMed Central 2008-12-15 /pmc/articles/PMC2868887/ /pubmed/20525136 http://dx.doi.org/10.1186/1710-1492-4-4-139 Text en Copyright ©2008 The Canadian Society of Allergy, Asthma and Clinical Immunology |
spellingShingle | Review Al-Ahmed, Nasser Alsowaidi, Shirina Vadas, Peter Peanut Allergy: An Overview |
title | Peanut Allergy: An Overview |
title_full | Peanut Allergy: An Overview |
title_fullStr | Peanut Allergy: An Overview |
title_full_unstemmed | Peanut Allergy: An Overview |
title_short | Peanut Allergy: An Overview |
title_sort | peanut allergy: an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868887/ https://www.ncbi.nlm.nih.gov/pubmed/20525136 http://dx.doi.org/10.1186/1710-1492-4-4-139 |
work_keys_str_mv | AT alahmednasser peanutallergyanoverview AT alsowaidishirina peanutallergyanoverview AT vadaspeter peanutallergyanoverview |